SUN Pharmaceutical Industries Limited Bortezomib Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Bortezomib Export Records India — #1 Exporter, 57 Shipments, $2.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Bortezomib

India Pharmaceutical Trade Intelligence

$21.9M200 Suppliers109 CountriesHS 30049049

ExportsIndia → BRAZIL28.3%India → UNITED STATES25.4%

ImportsITALY → India$200.0K UNITED STATES → India$72.1K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: EUGIA US

SUN Pharmaceutical Industries Limited — Bortezomib Exporter #1 | $2.9M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Bortezomib Exporter Profile

Indian Pharmaceutical Exporter · #1 for Bortezomib · $2.9M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #1 Indian exporter of Bortezomib with $2.9M in export value and 57 verified shipments. SUN Pharmaceutical Industries Limited holds a 13.0% market share in Bortezomib exports across 5 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Bortezomib Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Bortezomib export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Bortezomib?

Country	Value	Shipments	Share
BRAZIL	$1.3M	32	59.2%
BELGIUM	$669.5K	20	29.7%
PHILIPPINES	$189.0K	5	8.4%
ISRAEL	$50.0K	1

Who Are the Top Buyers of Bortezomib from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$669.5K	20
SUN FARMACEUTICA DO BRASIL LTDA	BRAZIL	$234.8K	6
SUN FARMACUTICA DO BRASIL LTDA	BRAZIL	$200.0K	4
SUN PHARMA PHILIPPINES INC.	PHILIPPINES	$189.0K	5
M/S. SUN FARMACEUTICA DO BRAZIL LTD	BRAZIL	$166.4K	4
SUN FARMACEUTICA DO BRAZIL LIMITEDA	BRAZIL	$152.7K	4
SUN FARMACUTICA DO BRASIL LIMITEDA	BRAZIL	$150.0K	3
SUN FARMACEUTICA DO BRASIL LTDA RUA	BRAZIL	$108.5K	3
SUN FARMACEUTICA DO BRAZIL LTDA.	BRAZIL	$82.2K	2
M/S	BRAZIL	$69.0K	2

SUN Pharmaceutical Industries Limited supplies Bortezomib to 16 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by SUN FARMACEUTICA DO BRASIL LTDA (BRAZIL) and SUN FARMACUTICA DO BRASIL LTDA (BRAZIL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Bortezomib Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
BORTEZOMIB FOR INJECTION 3.5 MG/VIAL. BO	$150.0K	3
ZOMI EACH CONTAINS BORTEZOMIB PACK : 01*	$132.2K	3
Bortezomib SUN 3,5 mg VL01*01 FI PACK :	$121.3K	3
ZOMI EACH CONTAINS BORTEZOMIB PACK : 01*01 Batch No. As Per DOCUMENT	$118.6K	3
BORTEZOMIB SUN 3,5 MG VL01*01 FI PACK :	$100.0K	2
BORTEZOMIB FOR INJECTION 3.5 MG VIAL. BO	$100.0K	2
BORTEZOMIB FOR INJECTION 3.5 MG/VIAL. BORTEZOMIB PACK : 01*01 Batch No. As Per DOCUMENT	$100.0K	2
BORTESUM INJ 3.5MG 1S VL PH (BORTEZOMIB	$88.7K	2
BORTEZOMIB FOR INJECTION 3.5 MG/VIAL. BORTEZOMIB (PACK:01x01)	$64.2K	2
BORTEZOMIB SUN INJ 3.5MG 1'S VL (BALT)LT(Bortezomib for Injection 3.5 mg /Vial,Lyophilized) (PACK : 1 Vial, Batch : HA	$55.4K	2

SUN Pharmaceutical Industries Limited exports 45 distinct Bortezomib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is BORTEZOMIB FOR INJECTION 3.5 MG/VIAL. BO with 3 shipments worth $150.0K.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Bortezomib Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	MSN LABORATORIES PRIVATE LIMITED	$3.6M	97	20	$37.0K
2	EUGIA PHARMA SPECIALITIES LIMITED	$3.5M	69	10	$50.0K
1	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$2.9M	57	5	$50.0K
4	VENUS REMEDIES LIMITED	$864.3K	44	16	$19.6K
5	FRESENIUS KABI ONCOLOGY LIMITED	$803.7K	99	10	$8.1K

SUN Pharmaceutical Industries Limited ranks #1 among 200 Indian Bortezomib exporters. Average shipment value of $50.0K compared to the market average of $68.4K. The closest competitors by value are MSN LABORATORIES PRIVATE LIMITED and EUGIA PHARMA SPECIALITIES LIMITED.

Which Indian Ports Ship Bortezomib Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	263	19.0%
SAHAR AIR	229	16.6%
DELHI AIR CARGO ACC (INDEL4)	168	12.1%
DELHI AIR	148	10.7%
HYDERABAD ACC (INHYD4)	82	5.9%
HYDERABAD AIR	82	5.9%
Bombay Air	62	4.5%
Bombay Air Cargo	32	2.3%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Bortezomib Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Bortezomib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 59 individual customs records matching SUN Pharmaceutical Industries Limited exporting Bortezomib, covering 45 formulations to 5 countries via 16 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 109+ countries, 498+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Bortezomib

Bortezomib

SUN Pharmaceutical Industries Limited — Bortezomib Exporter Profile

SUN Pharmaceutical Industries Limited — Bortezomib Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Bortezomib?

Who Are the Top Buyers of Bortezomib from SUN Pharmaceutical Industries Limited?

What Is India's Total Bortezomib Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Bortezomib Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Bortezomib Exporters?

What Bortezomib Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Bortezomib to Key Markets

Brazil — ANVISA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Bortezomib Exporters?

Which Indian Ports Ship Bortezomib Exports?

Bortezomib — Export Intelligence Video

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Bortezomib Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Bortezomib Export Data from SUN Pharmaceutical Industries Limited

Bortezomib Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source